Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2026-526531-18-00Phase 4Authorised
Phase 4, randomised, double-blind trial in postoperative pain comparing Intravenous Novalgine (metamizole) with Intravenous saline placebo (2 arms). Primary endpoint: Perioperative and early postoperative opioid consumption. Planned start Sep 2026; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2026-526531-18-00.